Immunogenetic mechanisms of antibody response to measles vaccine: The role of the HLA genes

Vaccine

Volumn 17, Issue 13-14, 1999, Pages 1719-1725

  Poland, Gregory A ^a  

^a Mayo Vaccine Research Group   (United States)

Author keywords

HLA; Immunogenetics; Measles; Vaccine response

Indexed keywords

HLA ANTIGEN; HLA DQ ANTIGEN; LEUKOCYTE ANTIGEN; MEASLES VACCINE;

ALLELE; ANTIBODY RESPONSE; COHORT ANALYSIS; CONFERENCE PAPER; DRUG EFFECT; GENETIC SUSCEPTIBILITY; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENETICS; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MEASLES VACCINATION; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, VIRAL; ATP-BINDING CASSETTE TRANSPORTERS; CHROMOSOME MAPPING; GENES, MHC CLASS I; GENES, MHC CLASS II; HLA-DR ANTIGENS; HUMANS; MEASLES VACCINE;

EID: 0344528767     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00429-0     Document Type: Conference Paper

References (52)

1. Haldane J.B.S. Disease and evolution. La Ricerca Sci. 19(Suppl.):1949;68-76.
2. Detels R., Mann D., Carrington M., Hennessey K., Wu Z., Hirji K.F., Wiley D., Visscher B.R., Giorgi J.V. Persistently seronegative men from whom HIV-1 has been isolated are genetically and immunologically distinct. Immunol. Lett. 51:1996;29-33.
3. Bodmer J. World distribution of HLA alleles and implications for disease. Ciba Foundation Symposium 1996, 197. pp. 233-258.
4. Singh N., Agrawal S., Rastogi A.K. Infectious diseases and immunity: special reference to major histocompatibility complex. Emerg. Infect. Dis. 3:1997;41-48.
5. Hope Simpson R.E. Infectiousness of communicable diseases in the household (measles, chickenpox and mumps). Lancet. 2:1952;549-554.
6. Centers for Disease Control and Prevention Measles: United States, 1990. MMWR. 40:1991;369-372.
7. Centers for Disease Control and Prevention. Measles: United States, 1989 and first 20 weeks 1990. MMWR 1990;39:353-355, 361-363.
8. Poland G.A., Jacobson R.M. Failure to reach the goal of measles elimination: apparent paradox of measles infections in immunized persons. Arch. Intern. Med. 154:1994;1815-1820.
9. Centers for Disease Control and Prevention Measles prevention: recommendations of the immunization practices advisory committee (ACIP). MMWR. 38:1989;11-14.
10. Wharton M., Cochi S.L., Williams W.W. Measles, mumps and rubella vaccines. Infect. Dis. Clin. N. Am. 4:1990;47-73.
11. Preblud SR, Katz SL. Measles vaccine. In: Plotkin SA, Mortimer Jr. EA, editors, Vaccines. Philadelphia, PA: W.B. Saunders, Co., 1988. p. 182 - 222.
12. Brunell P.A., Weigle K., Murphy D., Shehab Z., Cobb E. Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA. 250:1983;1409-1412.
13. Orenstein W.A., Herrmann K., Albrecht P., Bernier R., Holmgreen P., Bart K.J., Hinman A.R. Immunity against measles and rubella in Massachusetts schoolchildren. Develop. Biol. Standard. 65:1986;75-83.
14. Division of Microbiology and Infectious Diseases. Annual Report: The Jordan Report. National Institutes of Health. Bethesda, MD: National Institute of Allergy and Infectious Diseases. (Generic) Ref. Type: Report, 1995. p. 1-82.
15. Poland GA, Jacobson RM, Rabe D, Lipsky JJ, Wollan PC. The association between measles vaccine and mumps vaccine failure in a cohort of U.S. school children. Abstracts of the 35th ICAAC 1995, 184-#H24 (Abstract).
16. Anders J.F., Jacobson R.M., Poland G.A., Jacobsen S.J., Wollan P.C. Secondary failure rates of measles vaccines: a meta-analysis of published studies. Pediatr. Infect. Dis. J. 15:1996;62-66.
17. Rota J.S., Heath J.L., Rota P.A., King G.E., Celma M.L., Carabaña J., Fernandez-Muñoz R., Brown D., Jin L., Bellini W.J. Molecular epidemiology of measles virus: identification of pathways of transmission and implications for measles elimination. J. Infect. Dis. 173:1996;32-37.
18. Rota J.S., Wang Z.-D., Rota P.A., Bellini W.J. Comparison of sequences of the H, F and N coding genes of measles virus vaccine strains. Virus Res. 31:1994;317-330.
19. Rota J.S., Hummel K.B., Rota P.A., Bellini W.J. Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology. 188:1992;135-142.
20. Tamin A., Rota P.A., Wang Z., Heath J.L., Anderson L.J., Bellini W.J. Antigenic analysis of current wild type and vaccine strains of measles virus. J. Infect. Dis. 170:1994;795-801.
21. Rota P.A., Bloom A.E., Vanchiere J.A., Bellini W.J. Evolution of the nucleoprotein and matrix genes of wild-type strains of measles virus isolated from recent epidemics. Virology. 198:1994;724-730.
22. Poland G.A., Jacobson R.M. The genetic basis for variation in antibody response to vaccines. Curr. Opin. Pediatr. 10:1998;208-215.
23. Poland G.A. Variability in immune response to pathogens: using measles vaccine to probe immunogenetic determinants of response. Am. J. Hum. Genet. 62:1998;215-220.
24. McDevitt H.O., Bodmer W.F. Histocompatibility antigens, immune responsiveness and susceptibility to disease. Am. J. Med. 52(1):1972;1-8.
25. Huston D.P. The biology of the immune system. JAMA. 278:1997;1804-1814.
26. Baum H., Davies H., Peakman M. Molecular mimicry in the MHC: hidden clues to autoimmunity. Immunol. Today. 17(2):1996;64-70.
27. Ward FE, Tuan S, Haynes BF. Analysis of HLA Frequencies in Population Cohorts for Design of HLA-Based HIV Vaccines. Department of Immunology, Information Technology OIT and Medicine and the Duke Center for AIDS Research Duke University Medical Center. Durham, NC: HIV Molecular Immunology Database. (Generic) Ref. Type: Data file, 1995.
28. Dörig R.E., Marcil A., Chopra A., Richardson C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell. 75:1993;295-305.
29. Manchester M., Liszewski M.K., Atkinson J.P., Oldstone M.B.A. Multiple isoforms of CD46 (membrane cofactor protein) serve as receptors for measles virus. Proc. Natl. Acad. Sci. USA. 91:1994;2161-2165.
30. Schneider-Schaulies J., Dunster L.M., Schwartz-Albiez R., Krohne G., ter Meulen V. Physical association of moesin and CD46 as a receptor complex for measles virus. J. Virol. 69(4):1995;2248-2256.
31. Dunster L.M., Schneider-Schaulies J., ter Meulen V., Lankes W., Schwartz-Albiez R., Lottspeich F. Moesin: a cell membrane protein linked with susceptibility to measles virus infection. Virology. 198:1994;265-274.
32. Hayney M.S., Poland G.A., Dimanlig P., Schaid D.J., Jacobson R.M., Lipsky J.J. Polymorphisms of the TAP2 gene may influence antibody response to live measles vaccine virus. Vaccine. 15:1997;3-6.
33. *13 allele on measles vaccine response. J. Invest. Med. 44:1996;261-263.
34. Hayney MS, Schaid DJ, Jacobson RM, Lipsky JJ, Poland GA. Association of measles vaccine nonresponse and class II HLA-DR alleles. Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy 1994, 240-#H109 (Abstract).
35. Poland G.A., Hayney M.S., Schaid D.J., Jacobson R.M., Lipsky J.J. Class II HLA-DR homozygosity is associated with nonresponse to measles vaccine in US children. FASEB J. 9:1995;A240-1397. (Abstract).
36. *13 allele may be a marker for measles vaccine failure. J. Invest. Med. 43:1995;486A. (Abstract).
37. Hayney MS, Jacobson RM, Lipsky JJ, Schaid DJ, Poland GA. Is TAP gene polymorphism important in measles vaccine response? Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy 1994, 229-#H52 (Abstract).
38. Dimanlig P, Hayney MS, Lipsky JJ, Jacobson RM, Schaid DJ, Poland GA. The influence of TAP gene polymorphisms on the antibody response to live measles vaccine virus: preliminary results. Cold Spring Harbor Laboratory Conference on Molecular Approaches to the Control of Infectious Diseases 1994, 53 (Abstract).
39. Hayney M.S., Dimanlig P., Lipsky J.J., Jacobson R.M., Poland G.A. TAP2 allele heterozygosity at position 665 may predict measles vaccine antibody response. FASEB J. 9:1995;A240-1398. (Abstract).
40. Hayney M.S., Poland G.A., Jacobson R.M., Rabe D., Schaid D.J., Jacobsen S.J., Lipsky J.J. The relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination. Int. J. Infect. Dis. 2:1998;143-146.
41. Poland GA, Jacobson RM, Schaid DJ, Moore SB, Jacobsen SJ, Class I HLA alleles and measles vaccine-induced antibody levels: evidence of a significant association. Vaccine 1998 (in press).
42. Robbins J.B., Schneerson R., Szu S.C. Perspective: hypothesis: serum IgG antibody is sufficient to confer protection against infectious diseases by inactivating the inoculum. J. Infect. Dis. 171:1995;1387-1398.
43. Norrby E. The paradigms of measles vaccinology. Curr. Top. Microbiol. Immunol. 191:1995;167-180.
44. Griffin D.E., Ward B.J., Esolen L.M. Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J. Infect. Dis. 170:1994;S24-S31.
45. Rose J.W., Bellini W.J., McFarlin D.E., McFarland H.F. Human cellular immune response to measles virus polypeptides. J. Virol. 49:1984;988-991.
46. Krause P.J., Cherry J.D., Carney J.M., Naiditch M.J., O'Connor K. Measles-specific lymphocyte reactivity and serum antibody in subjects with different measles histories. Am. J. Dis. Child. 134:1980;567-571.
47. Hayney M.S., Poland G.A., Jacobson R.M., Rabe D., Schaid D.J., Jacobsen S.J., Lipsky J.J. Relationship of HLA-DQA1 alleles and humoral antibody following measles vaccination. Int. J. Infect. Dis. 2:1998;143-146.
48. Ovsyannikova IG, Rabe DE, Sohni Y, Shitaye H, Li H, Jacobson RM, Jacobsen J, Lipsky JJ, Poland GA. HLA-DPA1 alleles and measles vaccine antibody (Ab) response: preliminary results. First Annual Conference on Vaccine Research, 1998 (Abstract).
49. Hayney M.S., Dimanlig P., Lipsky J.J., Poland G.A. Utility of a 'swish and spit' technique for the collection of buccal cells for TAP haplotype determination. Mayo Clin. Proc. 70:1995;951-954.
50. Hedrick P.W. Evolution at HLA: possible explanations for the deficiency of homozygotes in two populations. Hum. Hered. 40:1990;213-220.
51. Black F.L., Salzano F.M. Evidence for heterosis in HLA system. Am. J. Hum. Genet. 33:1981;894-899.
52. Black FL, Pinheiro FD, Hierholzer WJ, Lee RV. Epidemiology of infectious disease: the example of measles. In: Anonymous Health and Disease in Tribal Societies. Amsterdam: Elsevier, 1977. p. 115-135.